ArticlePatterns (New York, N.Y.)2026
Revealing hidden material composition via physics-induced deep learning for precision clinical diagnosis.
Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Material-composition information extracted from spectral computed tomography (CT) images facilitates clinical diagnosis by characterizing pathological tissues. However, the complexity of human anatomy and the diversity of tissue types make precise material quantification from single-energy CT (SECT) highly challenging. Here, we propose an X-ray imaging induced multi-material decomposition (MMDX) framework. By integrating the physical principles of photoelectric effect and Compton scattering into a deep-learning network architecture, MMDX achieves superior performance on both phantom and clinical patient datasets, with a 12.92-dB improvement in peak signal-to-noise ratio (PSNR) and a 3.94% increase in volume fraction accuracy. To evaluate the clinical utility of MMDX, we constructed a large-scale clinical CT dataset with 1,637,738 CT images from 7,629 patients. MMDX demonstrates superior performance across 20 downstream tasks, including three diagnosis tasks, two prognosis tasks, and 15 biomarker prediction tasks, showing promise as an accessible AI tool for precision clinical diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.